• Accueil >
  • Publications >
  • Interruption versus continuation of trabectedin in patients with soft-tissue sarcoma (T-DIS): a randomised phase 2 trial

Interruption versus continuation of trabectedin in patients with soft-tissue sarcoma (T-DIS): a randomised phase 2 trial

1 mars 2015The Lancet Oncology

DOI : 10.1016/s1470-2045(15)70031-8

Auteurs

Axel Le Cesne, Jean-Yves Blay, Julien Domont, Emmanuelle Tresch-Bruneel, Christine Chevreau, François Bertucci, Corinne Delcambre, Esma Saada-Bouzid, Sophie Piperno-Neumann, Jacques-Olivier Bay, Olivier Mir, Isabelle Ray-Coquard, Thomas Ryckewaert, Thibaud Valentin, Nicolas Isambert, Antoine Italiano, Stéphanie Clisant, Nicolas Penel